Extraordinary biotechnological advances are bringing enormous benefits to medicine, public health, the food industry, agriculture and industrial processes.  At the same time, these advances can pose risks to public safety and security through the possibility of accidents, sabotage or misuse. Furthermore, humans continue to face natural biological risks such as pandemics. It is essential that the full spectrum of risk is properly identified, understood and mitigated through implementation of comprehensive biosafety and biosecurity strategies backed by legislative, regulatory, human and physical infrastructure.  


The advances in the life sciences and its globalization have spurred the rapid dissemination of information and capabilities around the world. Any effort to manage biological risk and maintain safety and security requires international collaboration of a high order to ensure the rewards of these advances can be fully exploited.

Through its networks, ICLS is addressing these challenges by facilitating partnerships between the different sectors of the life sciences community, such as pharmaceutical and biotechnology companies, academia, governments, IGOs and NGOs.

The ICLS approach is two-fold:

           1. Promoting regional networks to enhance biosafety and biosecurity                            and disease surveillance capacity;

           2. Developing convergence globally in two key technical areas: biological                     risk and synthetic biology.

Areas of Expertise:

  • Biosafety

  • Biosecurity

  • Biological and Toxin Weapons Convention (BTWC)

  • Bioterrorism

  • Codes of Conduct for the Life Sciences

  • Education and Training Programs for Biosafety and Biosecurity

  • Global Heath and Security

  • G8 Global Partnership
  • Risk Assessment